BMRN vs KVUE · P/E 40, rev $1.76B vs P/E 21, rev $15.12B
Biomarin Pharmaceutical Inc (BMRN) versus Kenvue Inc. (KVUE) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Kenvue Inc. (KVUE) is a household & personal products company listed on NYSE.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported KVUE revenue for 2025-12-28 was $15.12B. Net income was $1.47B. Revenue was down 2.1% from 2024-12-29 to 2025-12-28. KVUE currently screens at market cap $34.58B and trailing P/E 21.4.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. KVUE currently screens at market cap $34.58B and trailing P/E 21.4.
Not investment advice. Open the BMRN and KVUE stock pages for the full models.
Not investment advice.